Ceretype Neuromedicine
About:
Ceretype Neuromedicine is a next-generation fMRI brain biomarker platform to improve drug discovery and patient care in neuropsychiatry
Website: http://ceretype.com/
Top Investors: THE CATALYTIC IMPACT FOUNDATION (CIF), One Mind Accelerator, Leafy Tunnel, WPSS.bio, Cedar Street Group
Description:
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
$4.35M
$1M to $10M
Cambridge, Massachusetts, United States
2020-01-01
info(AT)ceretype.com
David Silbersweig, Emily Stern, Hong Pan
11-50
2024-01-01
Private
© 2025 bioDAO.ai